94D-60647-44396
3 vaccinations
2 coded responses
30 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 890 / NV
- Registered
- 2021-02-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-01
Registered in v-safe
-
2021-02-01
Dose 1 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-15
-
2021-02-22
Dose 2 — Pfizer-BioNTech
-
2021-02-22
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: Good · Headache, NauseaFree text: Nothing too crazy, just happened a little after the shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-05-24
- 2021-08-23
-
2021-09-07
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-12-08
- 2022-03-08
-
2022-09-09
Survey response — 12 months, dose 3MedDRA: Ageusia, Anosmia, COVID-19, Chills, Fatigue, Pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had COVID on July 8th, slight fever, chills, fatigue, body ache, runny nose, loss of smell and taste. The major symptoms were short lived (2 days), the minor ones lasted an extra week.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-09-07 | Pfizer-BioNTech | No |
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): Nothing too crazy, just happened a little after the shot.
Release 12 — 12 months, dose 3
Symptoms: I had COVID on July 8th, slight fever, chills, fatigue, body ache, runny nose, loss of smell and taste. The major symptoms were short lived (2 days), the minor ones lasted an extra week.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release